- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Meningococcal Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Meningococcal Disease Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Meningococcal Disease Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injectable segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Meningococcal Disease Drugs include Pfizer, GlaxoSmithKline, Sanofi Pasteur, Novartis, and Merck Sharp & Dohme, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Meningococcal Disease Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injectable
Oral
Market segment by Application can be divided into
Hospitals
Drugstores
Others
The key market players for global Meningococcal Disease Drugs market are listed below:
Pfizer
GlaxoSmithKline
Sanofi Pasteur
Novartis
Merck Sharp & Dohme
Hebei Hejia Pharmaceutical Technology Group Co., Ltd
Shandong Jincheng Pharmaceutical Group Co.,ltd.
Apeloa Pharmaceutical Co.,Ltd.
Yiling Pharmaceutical
Baiyunshan Pharmaceutical
SSY Group Limited
Lukang Pharmaceutical Co.,Ltd.
North China Pharmaceutical Company Ltd.
Harbin Pharmaceutical Group Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Disease Drugs, with price, sales, revenue and global market share of Meningococcal Disease Drugs from 2019 to 2022.
Chapter 3, the Meningococcal Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Meningococcal Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Disease Drugs.
Chapter 13, 14, and 15, to describe Meningococcal Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Meningococcal Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meningococcal Disease Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injectable
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Meningococcal Disease Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Meningococcal Disease Drugs Market Size & Forecast
1.4.1 Global Meningococcal Disease Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Meningococcal Disease Drugs Sales in Volume (2017-2028)
1.4.3 Global Meningococcal Disease Drugs Price (2017-2028)
1.5 Global Meningococcal Disease Drugs Production Capacity Analysis
1.5.1 Global Meningococcal Disease Drugs Total Production Capacity (2017-2028)
1.5.2 Global Meningococcal Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Meningococcal Disease Drugs Market Drivers
1.6.2 Meningococcal Disease Drugs Market Restraints
1.6.3 Meningococcal Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Meningococcal Disease Drugs Product and Services
2.1.4 Pfizer Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Meningococcal Disease Drugs Product and Services
2.2.4 GlaxoSmithKline Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business
2.3.3 Sanofi Pasteur Meningococcal Disease Drugs Product and Services
2.3.4 Sanofi Pasteur Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Meningococcal Disease Drugs Product and Services
2.4.4 Novartis Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck Sharp & Dohme
2.5.1 Merck Sharp & Dohme Details
2.5.2 Merck Sharp & Dohme Major Business
2.5.3 Merck Sharp & Dohme Meningococcal Disease Drugs Product and Services
2.5.4 Merck Sharp & Dohme Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hebei Hejia Pharmaceutical Technology Group Co., Ltd
2.6.1 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Details
2.6.2 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Major Business
2.6.3 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Product and Services
2.6.4 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shandong Jincheng Pharmaceutical Group Co.,ltd.
2.7.1 Shandong Jincheng Pharmaceutical Group Co.,ltd. Details
2.7.2 Shandong Jincheng Pharmaceutical Group Co.,ltd. Major Business
2.7.3 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Product and Services
2.7.4 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Apeloa Pharmaceutical Co.,Ltd.
2.8.1 Apeloa Pharmaceutical Co.,Ltd. Details
2.8.2 Apeloa Pharmaceutical Co.,Ltd. Major Business
2.8.3 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product and Services
2.8.4 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Yiling Pharmaceutical
2.9.1 Yiling Pharmaceutical Details
2.9.2 Yiling Pharmaceutical Major Business
2.9.3 Yiling Pharmaceutical Meningococcal Disease Drugs Product and Services
2.9.4 Yiling Pharmaceutical Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Baiyunshan Pharmaceutical
2.10.1 Baiyunshan Pharmaceutical Details
2.10.2 Baiyunshan Pharmaceutical Major Business
2.10.3 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Product and Services
2.10.4 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 SSY Group Limited
2.11.1 SSY Group Limited Details
2.11.2 SSY Group Limited Major Business
2.11.3 SSY Group Limited Meningococcal Disease Drugs Product and Services
2.11.4 SSY Group Limited Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Lukang Pharmaceutical Co.,Ltd.
2.12.1 Lukang Pharmaceutical Co.,Ltd. Details
2.12.2 Lukang Pharmaceutical Co.,Ltd. Major Business
2.12.3 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product and Services
2.12.4 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 North China Pharmaceutical Company Ltd.
2.13.1 North China Pharmaceutical Company Ltd. Details
2.13.2 North China Pharmaceutical Company Ltd. Major Business
2.13.3 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Product and Services
2.13.4 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Harbin Pharmaceutical Group Co.,Ltd.
2.14.1 Harbin Pharmaceutical Group Co.,Ltd. Details
2.14.2 Harbin Pharmaceutical Group Co.,Ltd. Major Business
2.14.3 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Product and Services
2.14.4 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Meningococcal Disease Drugs Breakdown Data by Manufacturer
3.1 Global Meningococcal Disease Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Meningococcal Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Meningococcal Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Meningococcal Disease Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Meningococcal Disease Drugs Manufacturer Market Share in 2021
3.5 Global Meningococcal Disease Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Meningococcal Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Meningococcal Disease Drugs Market Size by Region
4.1.1 Global Meningococcal Disease Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Meningococcal Disease Drugs Revenue by Region (2017-2028)
4.2 North America Meningococcal Disease Drugs Revenue (2017-2028)
4.3 Europe Meningococcal Disease Drugs Revenue (2017-2028)
4.4 Asia-Pacific Meningococcal Disease Drugs Revenue (2017-2028)
4.5 South America Meningococcal Disease Drugs Revenue (2017-2028)
4.6 Middle East and Africa Meningococcal Disease Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Meningococcal Disease Drugs Sales in Volume by Type (2017-2028)
5.2 Global Meningococcal Disease Drugs Revenue by Type (2017-2028)
5.3 Global Meningococcal Disease Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Meningococcal Disease Drugs Sales in Volume by Application (2017-2028)
6.2 Global Meningococcal Disease Drugs Revenue by Application (2017-2028)
6.3 Global Meningococcal Disease Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Meningococcal Disease Drugs Sales by Type (2017-2028)
7.2 North America Meningococcal Disease Drugs Sales by Application (2017-2028)
7.3 North America Meningococcal Disease Drugs Market Size by Country
7.3.1 North America Meningococcal Disease Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Meningococcal Disease Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Meningococcal Disease Drugs Sales by Type (2017-2028)
8.2 Europe Meningococcal Disease Drugs Sales by Application (2017-2028)
8.3 Europe Meningococcal Disease Drugs Market Size by Country
8.3.1 Europe Meningococcal Disease Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Meningococcal Disease Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Meningococcal Disease Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Meningococcal Disease Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Meningococcal Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Meningococcal Disease Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Meningococcal Disease Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Meningococcal Disease Drugs Sales by Type (2017-2028)
10.2 South America Meningococcal Disease Drugs Sales by Application (2017-2028)
10.3 South America Meningococcal Disease Drugs Market Size by Country
10.3.1 South America Meningococcal Disease Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Meningococcal Disease Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Meningococcal Disease Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Meningococcal Disease Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Meningococcal Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Meningococcal Disease Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Meningococcal Disease Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Meningococcal Disease Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Meningococcal Disease Drugs
12.3 Meningococcal Disease Drugs Production Process
12.4 Meningococcal Disease Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Meningococcal Disease Drugs Typical Distributors
13.3 Meningococcal Disease Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Disease Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Meningococcal Disease Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Meningococcal Disease Drugs Product and Services
Table 6. Pfizer Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Meningococcal Disease Drugs Product and Services
Table 10. GlaxoSmithKline Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Pasteur Major Business
Table 13. Sanofi Pasteur Meningococcal Disease Drugs Product and Services
Table 14. Sanofi Pasteur Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Meningococcal Disease Drugs Product and Services
Table 18. Novartis Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 20. Merck Sharp & Dohme Major Business
Table 21. Merck Sharp & Dohme Meningococcal Disease Drugs Product and Services
Table 22. Merck Sharp & Dohme Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Major Business
Table 25. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Product and Services
Table 26. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shandong Jincheng Pharmaceutical Group Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Shandong Jincheng Pharmaceutical Group Co.,ltd. Major Business
Table 29. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Product and Services
Table 30. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Apeloa Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Apeloa Pharmaceutical Co.,Ltd. Major Business
Table 33. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product and Services
Table 34. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Yiling Pharmaceutical Major Business
Table 37. Yiling Pharmaceutical Meningococcal Disease Drugs Product and Services
Table 38. Yiling Pharmaceutical Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Baiyunshan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Baiyunshan Pharmaceutical Major Business
Table 41. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Product and Services
Table 42. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. SSY Group Limited Basic Information, Manufacturing Base and Competitors
Table 44. SSY Group Limited Major Business
Table 45. SSY Group Limited Meningococcal Disease Drugs Product and Services
Table 46. SSY Group Limited Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Lukang Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Lukang Pharmaceutical Co.,Ltd. Major Business
Table 49. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product and Services
Table 50. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. North China Pharmaceutical Company Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. North China Pharmaceutical Company Ltd. Major Business
Table 53. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Product and Services
Table 54. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Harbin Pharmaceutical Group Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 56. Harbin Pharmaceutical Group Co.,Ltd. Major Business
Table 57. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Product and Services
Table 58. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Meningococcal Disease Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Meningococcal Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Meningococcal Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Meningococcal Disease Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Meningococcal Disease Drugs Production Site of Key Manufacturer
Table 64. Meningococcal Disease Drugs New Entrant and Capacity Expansion Plans
Table 65. Meningococcal Disease Drugs Mergers & Acquisitions in the Past Five Years
Table 66. Global Meningococcal Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Global Meningococcal Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Global Meningococcal Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Meningococcal Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Meningococcal Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Global Meningococcal Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Global Meningococcal Disease Drugs Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Meningococcal Disease Drugs Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Meningococcal Disease Drugs Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Meningococcal Disease Drugs Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Meningococcal Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Global Meningococcal Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Global Meningococcal Disease Drugs Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Meningococcal Disease Drugs Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Meningococcal Disease Drugs Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Meningococcal Disease Drugs Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Meningococcal Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 83. North America Meningococcal Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 84. North America Meningococcal Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Meningococcal Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Meningococcal Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 87. North America Meningococcal Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 88. North America Meningococcal Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 89. North America Meningococcal Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Europe Meningococcal Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Europe Meningococcal Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Europe Meningococcal Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Meningococcal Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Meningococcal Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Europe Meningococcal Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Europe Meningococcal Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Europe Meningococcal Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Meningococcal Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Meningococcal Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Meningococcal Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Meningococcal Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Meningococcal Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Meningococcal Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Meningococcal Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Meningococcal Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 106. South America Meningococcal Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 107. South America Meningococcal Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 108. South America Meningococcal Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Meningococcal Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Meningococcal Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 111. South America Meningococcal Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 112. South America Meningococcal Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 113. South America Meningococcal Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Meningococcal Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Meningococcal Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Meningococcal Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Meningococcal Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Meningococcal Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Meningococcal Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Meningococcal Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Meningococcal Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Meningococcal Disease Drugs Raw Material
Table 123. Key Manufacturers of Meningococcal Disease Drugs Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Meningococcal Disease Drugs Typical Distributors
Table 127. Meningococcal Disease Drugs Typical Customers
List of Figures
Figure 1. Meningococcal Disease Drugs Picture
Figure 2. Global Meningococcal Disease Drugs Revenue Market Share by Type in 2021
Figure 3. Injectable
Figure 4. Oral
Figure 5. Global Meningococcal Disease Drugs Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Drugstores
Figure 8. Others
Figure 9. Global Meningococcal Disease Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Meningococcal Disease Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Meningococcal Disease Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Meningococcal Disease Drugs Price (2017-2028) & (US$/Unit)
Figure 13. Global Meningococcal Disease Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Meningococcal Disease Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Meningococcal Disease Drugs Market Drivers
Figure 16. Meningococcal Disease Drugs Market Restraints
Figure 17. Meningococcal Disease Drugs Market Trends
Figure 18. Global Meningococcal Disease Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Meningococcal Disease Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Meningococcal Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Meningococcal Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Meningococcal Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Meningococcal Disease Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Meningococcal Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Meningococcal Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Meningococcal Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Meningococcal Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Meningococcal Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Meningococcal Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Meningococcal Disease Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Meningococcal Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Meningococcal Disease Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Meningococcal Disease Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Meningococcal Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Meningococcal Disease Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Meningococcal Disease Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Meningococcal Disease Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Meningococcal Disease Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Meningococcal Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Meningococcal Disease Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Meningococcal Disease Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Meningococcal Disease Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Meningococcal Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Meningococcal Disease Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Meningococcal Disease Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Meningococcal Disease Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Meningococcal Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Meningococcal Disease Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Meningococcal Disease Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Meningococcal Disease Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Meningococcal Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Meningococcal Disease Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Meningococcal Disease Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Meningococcal Disease Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Meningococcal Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Meningococcal Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Meningococcal Disease Drugs in 2021
Figure 77. Manufacturing Process Analysis of Meningococcal Disease Drugs
Figure 78. Meningococcal Disease Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
